CLRB
Cellectar Biosciences, Inc.
NASDAQ · USHealthcareBiotechnology
$2.52+0.40%
Price as of Jul 20, 2026
CLRB analysis
Cellectar Biosciences, Inc. stock analysis
Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.
Analysis for CLRB is not published yet
Browse the public research library while company-specific analysis is being prepared. Explore research